Andere talen VBI Vaccines Inc.

Aandelen

VBIV

CA91822J2020

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 30-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,571 ^USD	+1,24%		-6,16%	-2,81%

16/04	VBI Vaccines Inc. rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI
03/04	VBI Vaccines Inc. presenteert bemoedigende vroege tumorresponsgegevens van gerandomiseerde gecontroleerde fase 2b-studie van VBI-1901 in terugkerend glioblastoom	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

VBI Vaccines : 2023 Annual Report	17/04
VBI Vaccines Reports Full Year 2023 Financial Results	16/04
VBI Vaccines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16/04
North American Morning Briefing : Stock Futures -2-	15/04
VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	11/04
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	09/04
North American Morning Briefing : Inflation Data, -2-	08/04
VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma	03/04
VBI Vaccines Inc. Presents Encouraging Early Tumor Response Data from Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma	03/04
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform - VBI Vaccines	03/04
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform	02/04
VBI Vaccines Inc. Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA- Launched eVLP Vaccine Platform	02/04
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results	25/03
North American Morning Briefing : Tech in Focus on -2-	25/03
North American Morning Briefing : Investors -2-	18/03
North American Morning Briefing : Stock Futures -2-	11/03
Brii Biosciences Announces Agreements To Acquire VBI Vaccines' IP Rights In BRII-179	05/03
Thinking about buying stock in Arena Group, Dunxin Financial Holdings, Nano-X Imaging, VBI Vaccines, or SuRo Capital?	15/02
VBI Vaccines Sells Rights to Hepatitis B Vaccine to Brii Biosciences	14/02
VBI Vaccines Inc. Enter into New License Agreement with Brii Biosciences	14/02

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen VBI Vaccines Inc.

Aandelen

VBIV

CA91822J2020

Andere talen

Filters